BALAXI PHARMACEUTICALS
|
BALAXI PHARMACEUTICALS Last 5 Year Income Statement History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| INCOME : | |||||
| Gross Sales | ₹241 Cr | ₹336 Cr | ₹279 Cr | ₹231 Cr | ₹46 Cr |
| Sales | ₹241 Cr | ₹336 Cr | ₹279 Cr | ₹231 Cr | ₹46 Cr |
| Job Work/ Contract Receipts | - | - | - | - | - |
| Processing Charges / Service Income | - | - | - | - | - |
| Revenue from property development | - | - | - | - | - |
| Other Operational Income | - | - | - | - | - |
| Less: Excise Duty | - | - | - | - | - |
| Net Sales | ₹241 Cr | ₹336 Cr | ₹279 Cr | ₹231 Cr | ₹46 Cr |
| EXPENDITURE : | |||||
| Increase/Decrease in Stock | - | - | - | - | - |
| Raw Material Consumed | ₹129 Cr | ₹202 Cr | ₹196 Cr | ₹172 Cr | ₹33 Cr |
| Opening Raw Materials | - | - | - | - | - |
| Purchases Raw Materials | - | - | - | - | - |
| Closing Raw Materials | - | - | - | - | - |
| Other Direct Purchases / Brought in cost | - | - | - | - | - |
| Other raw material cost | ₹129 Cr | ₹202 Cr | ₹196 Cr | ₹172 Cr | ₹33 Cr |
| Power & Fuel Cost | ₹0.04 Cr | ₹0.28 Cr | ₹0.35 Cr | - | - |
| Electricity & Power | ₹0.04 Cr | ₹0.28 Cr | ₹0.35 Cr | - | - |
| Oil, Fuel & Natural gas | - | - | - | - | - |
| Coals etc | - | - | - | - | - |
| Other power & fuel | - | - | - | - | - |
| Employee Cost | ₹28 Cr | ₹29 Cr | ₹12 Cr | ₹8.47 Cr | ₹2.10 Cr |
| Salaries, Wages & Bonus | ₹28 Cr | ₹29 Cr | ₹12 Cr | ₹8.33 Cr | ₹2.00 Cr |
| Contributions to EPF & Pension Funds | - | - | - | - | - |
| Workmen and Staff Welfare Expenses | ₹0.26 Cr | ₹0.29 Cr | ₹0.22 Cr | ₹0.14 Cr | ₹0.10 Cr |
| Other Employees Cost | ₹0.04 Cr | - | - | - | - |
| Other Manufacturing Expenses | - | - | - | - | - |
| Sub-contracted / Out sourced services | - | - | - | - | - |
| Processing Charges | - | - | - | - | - |
| Repairs and Maintenance | - | - | - | - | - |
| Packing Material Consumed | - | - | - | - | - |
| Other Mfg Exp | - | - | - | - | - |
| General and Administration Expenses | ₹24 Cr | ₹35 Cr | ₹15 Cr | ₹5.28 Cr | ₹2.34 Cr |
| Rent , Rates & Taxes | ₹7.89 Cr | ₹9.91 Cr | ₹3.49 Cr | ₹1.21 Cr | ₹0.26 Cr |
| Insurance | ₹0.34 Cr | ₹0.21 Cr | ₹0.21 Cr | - | - |
| Printing and stationery | ₹1.03 Cr | ₹0.94 Cr | ₹0.52 Cr | ₹0.24 Cr | ₹0.16 Cr |
| Professional and legal fees | ₹4.43 Cr | ₹4.70 Cr | ₹3.01 Cr | ₹1.25 Cr | ₹0.19 Cr |
| Traveling and conveyance | ₹9.66 Cr | ₹13 Cr | ₹4.23 Cr | ₹0.80 Cr | ₹0.45 Cr |
| Other Administration | ₹0.83 Cr | ₹6.58 Cr | ₹3.52 Cr | ₹1.79 Cr | ₹1.27 Cr |
| Selling and Distribution Expenses | ₹0.66 Cr | ₹0.84 Cr | ₹1.02 Cr | ₹0.10 Cr | ₹0.10 Cr |
| Advertisement & Sales Promotion | ₹0.66 Cr | ₹0.84 Cr | ₹1.02 Cr | ₹0.10 Cr | ₹0.10 Cr |
| Sales Commissions & Incentives | - | - | - | - | - |
| Freight and Forwarding | - | - | - | - | - |
| Handling and Clearing Charges | - | - | - | - | - |
| Other Selling Expenses | - | - | - | - | - |
| Miscellaneous Expenses | ₹15 Cr | ₹12 Cr | ₹4.16 Cr | ₹2.65 Cr | ₹0.02 Cr |
| Bad debts /advances written off | - | - | - | ₹0.04 Cr | - |
| Provision for doubtful debts | - | - | - | - | - |
| Losson disposal of fixed assets(net) | ₹0.07 Cr | - | - | - | - |
| Losson foreign exchange fluctuations | ₹3.28 Cr | - | - | - | - |
| Losson sale of non-trade current investments | - | - | - | - | - |
| Other Miscellaneous Expenses | ₹12 Cr | ₹12 Cr | ₹4.16 Cr | ₹2.62 Cr | ₹0.02 Cr |
| Less: Expenses Capitalised | - | - | - | - | - |
| Total Expenditure | ₹197 Cr | ₹279 Cr | ₹229 Cr | ₹189 Cr | ₹37 Cr |
| Operating Profit (Excl OI) | ₹45 Cr | ₹57 Cr | ₹51 Cr | ₹43 Cr | ₹8.25 Cr |
| Other Income | ₹0.63 Cr | ₹2.64 Cr | ₹4.97 Cr | ₹2.23 Cr | ₹0.60 Cr |
| Interest Received | - | - | - | ₹0.00 Cr | - |
| Dividend Received | - | - | - | - | - |
| Profit on sale of Fixed Assets | - | - | - | - | - |
| Profits on sale of Investments | - | - | - | - | - |
| Provision Written Back | - | - | - | - | - |
| Foreign Exchange Gains | - | - | ₹4.94 Cr | ₹2.05 Cr | ₹0.56 Cr |
| Others | ₹0.63 Cr | ₹2.64 Cr | ₹0.03 Cr | ₹0.18 Cr | ₹0.03 Cr |
| Operating Profit | ₹45 Cr | ₹60 Cr | ₹56 Cr | ₹45 Cr | ₹8.85 Cr |
| Interest | ₹2.77 Cr | ₹1.38 Cr | ₹0.76 Cr | ₹0.28 Cr | ₹0.05 Cr |
| InterestonDebenture / Bonds | - | - | - | - | - |
| Interest on Term Loan | ₹0.57 Cr | ₹0.00 Cr | - | - | - |
| Intereston Fixed deposits | - | - | - | - | - |
| Bank Charges etc | ₹2.00 Cr | ₹0.88 Cr | ₹0.62 Cr | ₹0.26 Cr | ₹0.05 Cr |
| Other Interest | ₹0.20 Cr | ₹0.50 Cr | ₹0.14 Cr | ₹0.02 Cr | - |
| PBDT | ₹42 Cr | ₹59 Cr | ₹55 Cr | ₹45 Cr | ₹8.80 Cr |
| Depreciation | ₹2.10 Cr | ₹1.75 Cr | ₹0.51 Cr | ₹0.30 Cr | ₹0.01 Cr |
| Profit Before Taxation & Exceptional Items | ₹40 Cr | ₹57 Cr | ₹55 Cr | ₹44 Cr | ₹8.79 Cr |
| Exceptional Income / Expenses | ₹-38 Cr | - | - | - | - |
| Profit Before Tax | ₹2.02 Cr | ₹57 Cr | ₹55 Cr | ₹44 Cr | ₹8.79 Cr |
| Provision for Tax | ₹4.40 Cr | ₹11 Cr | ₹6.87 Cr | ₹6.19 Cr | ₹2.69 Cr |
| Current Income Tax | ₹3.94 Cr | ₹9.24 Cr | ₹6.83 Cr | ₹6.19 Cr | ₹2.69 Cr |
| Deferred Tax | ₹-0.11 Cr | ₹1.06 Cr | ₹0.03 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Other taxes | ₹0.57 Cr | ₹0.66 Cr | - | - | - |
| Profit After Tax | ₹-2.39 Cr | ₹46 Cr | ₹48 Cr | ₹38 Cr | ₹6.10 Cr |
| Extra items | - | - | - | - | - |
| Minority Interest | - | - | - | - | - |
| Share of Associate | - | - | - | - | - |
| Other Consolidated Items | ₹-4.92 Cr | ₹5.78 Cr | ₹0.53 Cr | ₹-0.90 Cr | ₹0.03 Cr |
| Consolidated Net Profit | ₹-7.31 Cr | ₹52 Cr | ₹48 Cr | ₹37 Cr | ₹6.13 Cr |
| Adjustments to PAT | - | - | - | - | - |
| Profit Balance B/F | ₹143 Cr | ₹92 Cr | ₹44 Cr | ₹6.45 Cr | ₹0.32 Cr |
| Appropriations | ₹136 Cr | ₹144 Cr | ₹92 Cr | ₹44 Cr | ₹6.45 Cr |
| General Reserves | - | - | - | - | - |
| Proposed Equity Dividend | - | - | - | - | - |
| Corporate dividend tax | - | - | - | - | - |
| Other Appropriation | - | ₹0.50 Cr | - | - | - |
| Equity Dividend % | - | - | ₹5.00 | - | - |
| Earnings Per Share | ₹-6.70 | ₹50.82 | ₹48.18 | ₹37.23 | ₹6.13 |
| Adjusted EPS | ₹-1.34 | ₹10.16 | ₹9.64 | ₹7.45 | ₹1.23 |
Compare Income Statement of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹159.5 Cr | 0.3% | -21.4% | -65.1% | Stock Analytics | |
| ADANI ENTERPRISES | ₹290,576.0 Cr | 0.7% | -6.3% | -3.4% | Stock Analytics | |
| REDINGTON | ₹21,502.7 Cr | 0.4% | -5.5% | 32.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹10,612.6 Cr | 9.4% | 20.3% | 71.4% | Stock Analytics | |
| HONASA CONSUMER | ₹8,846.8 Cr | 5.6% | -6.3% | 3.4% | Stock Analytics | |
| MMTC | ₹8,601.0 Cr | 6.2% | -4.8% | -25.5% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 0.3% |
-21.4% |
-65.1% |
| SENSEX | 1% |
0.3% |
6.7% |
You may also like the below Video Courses